Standout Papers

Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer 2005 2026 2012 2019 2.3k
  1. Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer (2007)
    Kathy D. Miller, Molin Wang et al. New England Journal of Medicine
  2. The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP (2006)
    Laurie H. Sehn, Brian Berry et al. Blood
  3. Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma (2005)
    Lauren E. Abrey, Tracy T. Batchelor et al. Journal of Clinical Oncology

Immediate Impact

3 by Nobel laureates 5 from Science/Nature 78 standout
Sub-graph 1 of 14

Citing Papers

Targeting the tumour vasculature: from vessel destruction to promotion
2024 Standout
Primary brain tumours in adults
2023 Standout
43 intermediate papers

Works of Tamara Shenkier being referenced

Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
2007 Standout
Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma
2005 Standout

Author Peers

Author Last Decade Papers Cites
Tamara Shenkier 3589 3350 1983 64 6.2k
Maurice Tubiana 3364 2383 976 81 6.4k
Bernd Metzner 3314 2866 1000 123 5.5k
Kieron Dunleavy 3450 2610 1285 145 5.4k
Richard Klasa 5680 3964 1476 104 7.3k
Marco Ladetto 4137 2884 936 170 7.0k
Félix Reyes 5367 3641 1695 55 7.3k
Catherine Sebban 3239 2936 1103 92 5.4k
Carol S. Portlock 4095 2639 1325 119 5.5k
Éric Van Den Neste 5335 4120 1550 45 7.0k
Edie Weller 2904 3141 782 129 7.4k

All Works

Loading papers...

Rankless by CCL
2026